On this episode, PrecisCa speaks with Dr. Sara Hurvitz, medical oncologist & the Director of Breast Oncology at the David Geffen School of Medicine at UCLA. Dr. Hurvitz answers the following: What are the biggest advances in breast cancer in 2021? What is your current approach to metastatic triple negative breast cancer? How do you choose between CDK4/6 inhibitors in both the curative and metastatic settings? How do you treat metastatic HER2 positive breast cancer with organ dysfunction through various lines of therapy? Did we learn any new information about T-DXD (Enhertu) in 2021? How d ..read more

On this episode, PrecisCa speaks with Dr. Michael Lanuti, an Associate Professor of Surgery at Harvard Medical School & the Director of Thoracic Oncology, Division of Thoracic Surgery at Massachusetts General Hospital.   Dr. Lanuti sits down with PrecisCa to discuss the following: What tests need to be ordered before surgery for lung cancer? Which patient should not undergo surgery for lung cancer? What is a sleeve resection? What is the role of pulmonary function testing and who should be tested? How many days do patients spend in the hospital with various types of lung surgery? Wha ..read more

On this episode, PrecisCa speaks with Dr. Michael Lanuti, an Associate Professor of Surgery at Harvard Medical School & the Director of Thoracic Oncology, Division of Thoracic Surgery at Massachusetts General Hospital.   Dr. Lanuti sits down with PrecisCa to discuss the following: What are some of the surgical techniques employed to preserve lung tissue? What tests need to be ordered before surgery for lung cancer? Which patient should not undergo surgery for lung cancer? What is a sleeve resection? What is the role of pulmonary function testing and who should be tested? How many day ..read more

On this episode, PrecisCa speaks with Dr. Joyce O'Shaughnessy, a medical oncologist and the Director of Breast Cancer Research Program at Baylor University Medical Center in Dallas, Texas.    Joyce A. O’Shaughnessy, M.D. focuses on breast cancer prevention and treatment. She is Co-Chair of Breast Cancer Research and Chair of Breast Cancer Prevention Research at Baylor-Sammons Cancer Center and for The US Oncology Network and is a member of the Scientific Advisory Board for US Oncology Research Network. In 2009 D Magazine elected Dr. O’Shaughnessy as one of the best hematology oncolog ..read more

On this episode, PrecisCa speaks with Dr. Suresh Ramalingam, medical oncologist and Executive Director at the Winship Cancer Institute of Emory University in Atlanta, Georgia.   Board certified in medical oncology, Suresh S. Ramalingam, MD, FACP, FASCO, is nationally recognized as an investigator and a physician in the area of small cell and non-small cell lung cancer. Dr. Ramalingam serves as executive director of Winship Cancer Institute of Emory University and associate vice president for cancer of Woodruff Health Sciences Center. He is past-president of the Georgia Society of Oncology ..read more

On this episode, PrecisCa speaks with Yi-Bin Chen MD, MS. Dr. Chen is the Director of the Transplant and Cell Therapy program at  Massachusetts General Hospital/Harvard Medical School -- uniting the programs of conventional transplant and emerging cellular therapies. His clinical interests mainly revolve around improving the outcomes of patients undergoing autologous and allogeneic stem cell transplantation.     Yi-Bin Chen grew up in New Jersey. He majored in molecular biophysics and biochemistry, earning a B.S./M.S. at Yale University before attending medic ..read more

On this episode, PrecisCa speaks with David M. Schuster MD, FACR. Dr. Schuster is a Professor in the Department of Radiology and Imaging Sciences at Emory University School of Medicine. Dr. Schuster also serves as Director of the Division of Nuclear Medicine and Molecular Imaging, and is a Georgia Research Alliance Distinguished Scientist. Board certified in radiology and nuclear medicine, he specializes in molecular medicine and integrative imaging. Dr. Schuster sits down with us to explain PET Scans, false readings & the importance of selecting the right scanners for the right ..read more

Dr. Collins graduated from the University of Florida with a Bachelor of Science in Biology and again with her Master of Science in Human Nutrition. She started her career with the National Institute of Health Clinical Research Center in Charlottesville, VA. In 2007 she graduated from the University of Tennessee, Knoxville with her Ph.D. in Experimental Psychology after defending her research dissertation: “Hope, Coping Style, Quality of Life, Knowledge about Cancer and risks for Dietary Deficiency in Patients with Total Gastrectomy for Stomach Cancer.” She is also a registered dietitian with t ..read more

On this episode we hear from Thoracic Medical oncologist Dr. Thomas Stinchcombe. Dr. Stinchcombe is a member of Duke Cancer Institute, and Thoracic Oncology Program at Duke University in Durham, North Carolina. Dr. Stinchcombe explains whether or not they would recommend RET inhibitors as first line therapy for a RET-fusion positive metastatic Non-Small Cell Lung Cancer patient, what drugs are available to treat patients with Non-Small Lung Cancer and MET exon 14 skipping alterations, the significance of a metastatic Non-Small Cell Lung Cancer patient with a ERBB2 or HER2 alteration & whet ..read more

On this episode we hear from Dr. Monica Morrow.  Dr. Morrow is Anne Burnett Windfohr Chair of Clinical Oncology, Professor of Surgery at Memorial Sloan Kettering Cancer Center in New York City. She is a surgical oncologist with a practice dedicated to the treatment of breast cancer. Her research has focused on how to apply the advances from clinical trials to daily surgical practice. Her research interests include how treatment choices for breast cancer surgery are made and identifying factors which predict for successful lumpectomy ..read more